BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Distributed Bio and Boehringer Ingelheim Announce SuperHuman Platform Transfer

  Distributed Bio announce an agreement with Boehringer Ingelheim to license the Distributed Bio SuperHuman Platform for accelerating biotherapeutics discovery across therapeutic areas.

  December 11, 2017

   · 

  2 min read
• Policy

  PharmaCyte Biotech Meets With Oncology Advisory Board

  PharmaCyte Biotech announced that it recently met with its Oncology Advisory Board, which was formed to assist in optimizing and finalizing the clinical protocol and other clinical trial-related matters.

  December 11, 2017

   · 

  4 min read
• Genetown

  Alnylam Announces Expansion of U.S. Orphan Drug Designation for Patisiran to Treatment of Transthyretin-Mediated Amyloidosis

  Alnylam announced today the FDA has granted a request to amend the orphan drug designation for patisiran to the treatment of transthyretin-mediated amyloidosis (ATTR amyloidosis).

  December 11, 2017

   · 

  8 min read
• Pharm Country

  Biotech Investors and Leaders to Headline 10th Annual Biotech Showcase™ 2018

  Understanding the health of the life sciences and biotech industries involves dissecting the past year’s successes.

  December 11, 2017

   · 

  6 min read
• 

  FDA

  FDA Green Lights Intersect ENT’s SINUVA Sinus Implant

  The implant is a new targeted approach to treating recurrent nasal polyp disease in patients who have had previous ethmoid sinus surgery.

  December 11, 2017

   · 

  7 min read
• Business

  Restoration Robotics Announces Appointment of Mark Hair as CFO

  Mr. Hair brings with him over 20 years of executive management, financial advisory, consulting, and public company experience.

  December 11, 2017

   · 

  2 min read
• Drug Development

  Altimmune Submits Investigational New Drug Application for NasoShield in Preparation for its Phase I Trial

  145 Patients to be enrolled in the trial.

  December 11, 2017

   · 

  4 min read
• Business

  Bay Area’s Graybug Vision Adds Four Top Execs to the Roster

  The company announced the addition of four key members to its leadership team as it continues to advance its novel ocular treatments through clinical development and evolve into a commercial biotech company.

  December 11, 2017

   · 

  5 min read
• Business

  Kimberly Blackwell, M.D., to Become VP of Early Phase Development and Immuno-Oncology at Lilly Oncology

  Eli Lilly today announced that Kimberly Blackwell, M.D. will join Lilly Oncology as VP of early phase development and immuno-oncology on March 12, 2018.

  December 11, 2017

   · 

  3 min read
• Business

  BD Establishes Product Security Partnership Program to Enhance Cybersecurity of Medical Technology

  BD today announced it has established a Product Security Partnership Program that emphasizes collaboration across the health care industry to enhance cybersecurity of medical technology and devices.

  December 11, 2017

   · 

  5 min read